Many studies showed that CXCL3 is highly expressed in many different types of cancers, including breast cancer, prostate cancer, cervical cancer, and ovarian cancer, and its up-regulated expression is closely related to clinical characteristics. This evidence concerns the gene CXCL3 and breast cancer.